Results
1
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
1 companies
Neuren Pharmaceuticals
Market Cap: AU$1.7b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$13.88
7D
7.8%
1Y
-35.9%